Key result
Proposed framework guides radiotherapy management to prevent implanted cardiac device failures during treatment.
Why the study?
Managing radiotherapy patients with modern implantable cardiac pacemakers and defibrillators poses practical challenges, and substantial literature on radiation effects has emerged since AAPM TG-34 in 1994.
This task group report provides a comprehensive framework and methodology for managing radiotherapy patients with implanted cardiac pacemakers and defibrillators.
Framework supports safer radiotherapy in device patients; extends 1994 guidelines while leaving prospective validation open.
Managing radiotherapy patients with implanted cardiac devices (implantable cardiac pacemakers and implantable cardioverter‐defibrillators) has been a great practical and procedural challenge in radiation oncology practice. Since the publication of the AAPM TG‐34 in 1994, large bodies of literature and case reports have been published about different kinds of radiation effects on modern technology implantable cardiac devices and patient management before, during, and after radiotherapy. This task group report provides the framework that analyzes the potential failure modes of these devices and lays out the methodology for patient management in a comprehensive and concise way, in every step of the entire radiotherapy process.
No takes yet. Share an insight, caveat, or question.
Miften et al. (2019) studied this question. The report outlines an effective framework for managing radiotherapy in patients with implanted cardiac devices, addressing potential device failures during treatment.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: